Thursday, April 14, 2011

Insulin patch developer Calibra raises $8.1M, including $1M in canceled debt

Calibra Medical Inc., a developer of a needle-free insulin patch-pen, raised $8.1 million in financing.
The investors were not disclosed in a Securities and Exchange Commission filing Thursday, but the company said the total included more than $1 million of canceled debt.
The Redwood City company, which had been known as Seattle Medical Technologies and moved to the Bay Area in 2007, said in the SEC filing that it is seeking $21.9 million more.

No comments:

Post a Comment